Spanish Society of Arteriosclerosis Standards 2026: A compass for vascular risk management [0.03%]
2026年西班牙动脉粥样硬化标准协会准则——血管风险管理的指南针
Jose María Mostaza
Jose María Mostaza
Physiological network analysis of arterial stiffness, hemodynamic parameters and aortic architecture in patients with and without hypertension [0.03%]
高血压患者和非高血压患者的动脉僵硬度、血流动力学参数和主动脉结构的生理网络分析
Alberto Guevara-Tirado
Alberto Guevara-Tirado
Introduction: Hypertension is associated with vascular remodeling and hemodynamic alterations; however, the global interaction of these processes remains insufficiently understood. ...
Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk [0.03%]
1型糖尿病的脂质预防：从估计风险到累计风险
Inka Miñambres,Antonio Pérez
Inka Miñambres
Dietary Guidelines for Americans (DGA) 2025-2030: Similarities and contrasts with the recommendations document of the Spanish Society of Atherosclerosis (SEA) (2024 update) [0.03%]
《美国人膳食指南（DGA）2025-2030：与西班牙动脉粥样硬化学会（SEA）推荐文件（2024更新版）的相似性和差异性》
Pablo Pérez-Martínez,José M Ordovás
Pablo Pérez-Martínez
Pilot study evaluating a clinical decision support tool: "Virtual Lipidologist HTE-DLP 3.0" [0.03%]
关于“虚拟脂质专家HTE-DLP 3.0”的临床决策支持工具评估研究试点项目
Alberto Zamora,Cristina Soler,Emilio Ortega et al.
Alberto Zamora et al.
Introduction: Clinical decision support systems can improve guideline adherence and reduce variability. HTE-DLP 3.0 (Virtual Lipidologist) provides recommendations based on scientific evidence, safety, and cost-effectiven...
José María Mostaza,Xavier Pintó,Pedro Armario et al.
José María Mostaza et al.
Vascular diseases are the main cause of mortality in Spain, are associated with a high degree of disability and involve high healthcare costs. The Spanish Society of Arteriosclerosis meets this challenge by trying to improve the knowledge, ...
Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit [0.03%]
代谢紊乱人群脂蛋白(a)水平升高及其与动脉粥样硬化性心血管疾病相关性的流行病学研究：来自血脂专病门诊的真实世界数据
Francesco Di Giacomo Barbagallo,Ana González-Lleó,Núria Amigo et al.
Francesco Di Giacomo Barbagallo et al.
Background and aims: Lipoprotein(a) (Lp(a)) is a proatherogenic particle that is considered an important cardiovascular risk modifier due to its association with atherosclerotic cardiovascular disease (ASCVD) as well as c...
Atherogenic Risk in Commerce and Industry Workers: Associations with Sociodemographic and Lifestyle Factors in a Large Spanish Occupational Cohort [0.03%]
商业和工业从业人员的致动脉粥样硬化风险：大型西班牙职业队列中社会人口学和生活方式因素的相关性分析
María Pilar Fernández-Figares Vicioso,María Teófila Vicente-Herrero,Pere Riutord Sbert et al.
María Pilar Fernández-Figares Vicioso et al.
Background: Atherogenic dyslipidemia (AD) and associated lipid ratios are critical markers for cardiovascular risk, yet little is known about how these markers vary by occupational sector and sociodemographic or lifestyle...
Importance of cardiovascular and atherogenic risk in healthcare professionals [0.03%]
医疗专业人员的心血管和动脉硬化风险的重要性
Johanna Vicuña
Johanna Vicuña
Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study [0.03%]
CORDIOPREV研究中短端粒作为2型糖尿病标志的风险
Ana Ojeda-Rodriguez,Maria Jose Parraga-Viudez,Juan L Romero-Cabrera et al.
Ana Ojeda-Rodriguez et al.
Background: The presence of type 2 diabetes mellitus (T2DM) in cardiovascular disease (CVD) is associated with poorer clinical outcomes. To identify biomarkers is essential to predict T2DM onset and progression in the con...